Chroniques génomiques - CRISPR-Cas9, une nouvelle donne pour la thérapie génique
Résumé
Targeted modification of genes (“gene editing”) is made much easier by the recently developed CRISPR-Cas9 system. This has raised alarm about possible uses of this technology for germline modification of the human genome; however this technology has less controversial applications, notably for somatic gene therapy with already some striking demonstrations in animal systems. Because of its precision and relative ease of use, CRISPR can be expected to drive a revolution in gene therapy and to turn it into a more mainstream approach.
Pour citer ce document
Jordan, Bertrand ; CRISPR-Cas9, une nouvelle donne pour la thérapie génique, Med Sci (Paris), 2015, Vol. 31, N° 11 ; p. 1035-1038 ; DOI : 10.1051/medsci/20153111018